The clinical approach to the detection of lipodystrophy - an AACE consensus statement - Wikidata - awgldk - TriplyDB

The clinical approach to the detection of lipodystrophy - an AACE consensus statement

The clinical approach to the detection of lipodystrophy - an AACE consensus statement

http://www.wikidata.org/entity/Q33939518

about

Fitting the pieces of the puzzle together: a case report of the Dunnigan-type of familial partial lipodystrophy in the adolescent girl Lipodystrophy syndromes Novel forms of lipodystrophy: why should we care?Efficacy and Safety of Metreleptin in Patients with Partial Lipodystrophy: Lessons from an Expanded Access Program.The role of adipokines in the rapid antidepressant effects of ketamine.The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.Metreleptin Treatment in Three Patients with Generalized Lipodystrophy.Glucagon-like peptide-1 analogues - an efficient therapeutic option for the severe insulin resistance of lipodystrophic syndromes: two case reports Associations Between At-Risk Alcohol Use, Substance Use, and Smoking with Lipohypertrophy and Lipoatrophy Among Patients Living with HIV.Facial soft tissue volume decreases during metreleptin treatment in patients with partial and generalized lipodystrophy.Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges.Effects of Metreleptin in Pediatric Patients With Lipodystrophy.Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort.Circulating serum chemerin levels are elevated in lipodystrophy.Novel peroxisome proliferator-activated receptor gamma mutation in a family with familial partial lipodystrophy type 3.

P2860

Q33362767-91404DAE-5958-494A-9CD5-B048ECD24CCF Q34597209-FF61889E-AC43-47E3-B25E-58BAD3144897 Q37022579-632CE0E3-EECB-4F1D-B79A-BA4A173A6CC0 Q37261712-C599F285-38EA-4864-B8A5-54B5B125B11A Q37418553-C0063AAC-14BA-4878-843C-F3C0FC4FF42E Q37502548-1A3E324F-F0FA-470B-8493-DEF81E3BA6B3 Q37567810-CE29157D-D196-4865-8BC6-E6B889909D11 Q37586919-699E4CE0-2D85-4935-8EA1-48CC535C6D78 Q40379251-3595EC62-872E-4227-8129-7D930EACE799 Q41921123-BF320B78-E830-4B4E-B4FE-E2841C678CE4 Q42736020-9BBAD67E-D5BC-44F3-A664-90D5D07A8AF7 Q47821479-4776AFB7-EFE6-46A3-83E6-19832153FFD8 Q47859313-FBFFAD02-C492-45DB-BEFC-FD16D89140DE Q48103693-F84AD484-0BE4-47B2-9C57-C2FE2DC53A23 Q51011749-80B0E391-A487-40A6-B5E5-DAB2C1FF4EE4

P2860

The clinical approach to the detection of lipodystrophy - an AACE consensus statement

http://www.wikidata.org/entity/Q33939518

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

The clinical approach to the detection of lipodystrophy - an AACE consensus statement

@ast

The clinical approach to the detection of lipodystrophy - an AACE consensus statement

@en

type

label

The clinical approach to the detection of lipodystrophy - an AACE consensus statement

@ast

The clinical approach to the detection of lipodystrophy - an AACE consensus statement

@en

prefLabel

The clinical approach to the detection of lipodystrophy - an AACE consensus statement

@ast

The clinical approach to the detection of lipodystrophy - an AACE consensus statement

@en

P1433

Q33939518-F3EAB5ED-12D7-4294-8B8D-BF4C30DE6A0C

P1476

Q33939518-19982367-26F3-4D1E-A4D6-F6296A765C01

P2093

Q33939518-17B01CDE-A154-445B-88F8-2D86162BB2CF

Q33939518-1941EFA2-3DE6-4627-A6C5-DD54DDCEC452

Q33939518-2884E50A-182C-461A-BA57-3F39CF19B784

Q33939518-303A7FE4-1A72-4E1A-9FC1-1378CDB0EC1F

Q33939518-3DCCBEAF-1017-4D57-9CFF-9A731303E75C

Q33939518-504B4B06-4D9F-426F-B7D2-F8618AC6D270

Q33939518-71393E84-4892-4486-A95B-80413DAAA0B5

Q33939518-71EDB391-38F4-479A-89D7-5201763B03A4

Q33939518-73E3C24E-2A53-406D-AA1E-82BA570DB4CB

Q33939518-7C5D14F1-76C9-4579-8C2D-1E1664BE43EE

P2860

Q33939518-089A72B8-0FA4-4902-A890-A3A4107BB617

Q33939518-0FE3A776-07C7-436F-AF91-C1FB5C749DBE

Q33939518-15A74969-4214-41D6-8E11-2EAE957A7FC3

Q33939518-1DACA9A8-0306-48B1-9A9A-B03104BD9D1F

Q33939518-1E96EC7E-6A97-4082-9F41-91DDCB5289E1

Q33939518-23BFCDB0-9AE8-41A9-B995-001D3916B861

Q33939518-256489DA-064B-47B6-A7B4-578348F6A7E6

Q33939518-32CF8672-D38F-4EDC-888B-E99671864220

Q33939518-4886C3E9-AE2D-4189-9B6C-D746E126434D

Q33939518-49EC8D7E-EDF2-47D5-B30B-4669E34E2158

P304

Q33939518-10937AE5-2121-4018-84AC-CE841394A660

P31

Q33939518-0744319F-4DFD-4940-B295-1660FD2E3E2D

P356

Q33939518-CB85CC63-C648-4BFB-8228-6C3F14C802CB

P433

Q33939518-B0D4AC20-C065-40A9-8071-A9DAC3687881

P478

Q33939518-40EDB86D-E483-419A-86C9-C671D043FA5F

P50

Q33939518-3F94F202-7DBC-46F0-8696-E7F26B7352C3

P577

Q33939518-F613FE3E-F07E-41A9-970B-CB64016102C2

P698

Q33939518-F92577BE-15EE-4FF4-AE51-1C022E1B7CCF

P932

Q33939518-FAD1B648-B119-4389-B8A2-599D2055BAE6

P356

ENDP.19.1.V767575M65P5MR06

P1433

Endocrine Practice

P1476

The clinical approach to the detection of lipodystrophy - an AACE consensus statement

@en

P2093

Abhimanyu Garg

http://www.w3.org/2001/XMLSchema#string

Alan J Garber

http://www.w3.org/2001/XMLSchema#string

American Association of Clinical Endocrinologists

http://www.w3.org/2001/XMLSchema#string

Carmen D Tapiador

http://www.w3.org/2001/XMLSchema#string

Christian Weyer

http://www.w3.org/2001/XMLSchema#string

Daniel Einhorn

http://www.w3.org/2001/XMLSchema#string

Elif A Oral

http://www.w3.org/2001/XMLSchema#string

George Grunberger

http://www.w3.org/2001/XMLSchema#string

Jean L Chan

http://www.w3.org/2001/XMLSchema#string

Norman Lavin

http://www.w3.org/2001/XMLSchema#string

P2860

Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC

Clinical review#: Lipodystrophies: genetic and acquired body fat disorders

Adipose tissue as an endocrine organ

Lipodystrophies.

Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature.

Acquired and inherited lipodystrophies.

Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C).

Clinical features and metabolic derangements in acquired generalized lipodystrophy: case reports and review of the literature.

Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A/C mutations

Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy.

P304

107-116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4158/ENDP.19.1.V767575M65P5MR06

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Zachary T Bloomgarden

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23435042

http://www.w3.org/2001/XMLSchema#string

P932

4108221

http://www.w3.org/2001/XMLSchema#string